{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:20:01Z","timestamp":1771950001390,"version":"3.50.1"},"reference-count":18,"publisher":"Zhejiang University Press","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1631\/jzus.b2300232","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:02:16Z","timestamp":1702573336000},"page":"1159-1164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review","1\u4f8b\u82a6\u53ef\u66ff\u5c3c\u6210\u529f\u6551\u6cbb\u514d\u75ab\u529f\u80fd\u6b63\u5e38\u60a3\u8005\u56e0\u5de8\u7ec6\u80de\u75c5\u6bd2\u611f\u67d3\u5bfc\u81f4\u55dc\u8840\u7ec6\u80de\u7efc\u5408\u5f81\u7684\u75c5\u4f8b\u62a5\u544a\u53ca\u6587\u732e\u56de\u987e"],"prefix":"10.1631","volume":"24","author":[{"given":"Fangfang","family":"Geng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-304X","authenticated-orcid":false,"given":"Jianhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"5","key":"232_CR1","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3109\/10428194.2014.963082","volume":"56","author":"YH Chen","year":"2015","unstructured":"Chen YH, Lee CH, Pei SN, 2015. Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis. Leuk Lymphoma, 56(5):1528\u20131529. https:\/\/doi.org\/10.3109\/10428194.2014.963082","journal-title":"Leuk Lymphoma"},{"issue":"13","key":"232_CR2","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","volume":"127","author":"R Das","year":"2016","unstructured":"Das R, Guan P, Sprague L, et al., 2016. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood, 127(13):1666\u20131675. https:\/\/doi.org\/10.1182\/blood-2015-12-684399","journal-title":"Blood"},{"key":"232_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1128\/microbiolspec.DMIH2-0022-2015","volume":"4","author":"MV Dioverti","year":"2016","unstructured":"Dioverti MV, Razonable RR, 2016. Cytomegalovirus. Microbiol Spectr, 4:4. https:\/\/doi.org\/10.1128\/microbiolspec.DMIH2-0022-2015","journal-title":"Microbiol Spectr"},{"issue":"10","key":"232_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1631\/jzus.B2200195","volume":"23","author":"ZR Gao","year":"2022","unstructured":"Gao ZR, Ling XY, Shi CY, et al., 2022. Tumor immune checkpoints and their associated inhibitors. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10):823\u2013843. https:\/\/doi.org\/10.1631\/jzus.B2200195","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"9","key":"232_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"C Harrison","year":"2012","unstructured":"Harrison C, Kiladjian JJ, Al-Ali HK, et al., 2012. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med, 366(9):787\u2013798. https:\/\/doi.org\/10.1056\/NEJMoa1110556","journal-title":"N Engl J Med"},{"issue":"21","key":"232_CR6","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.3390\/jcm11216308","volume":"11","author":"K He","year":"2022","unstructured":"He K, Xu SS, Shen LJ, et al., 2022. Ruxolitinib as adjunctive therapy for hemophagocytic lymphohistiocytosis after liver transplantation: a case report and literature review. J Clin Med, 11(21):6308. https:\/\/doi.org\/10.3390\/jcm11216308","journal-title":"J Clin Med"},{"issue":"7","key":"232_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1182\/blood-2013-03-484642","volume":"122","author":"A Heine","year":"2013","unstructured":"Heine A, Held SA, Daecke SN, et al., 2013. The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood, 122(7):1192\u20131202. https:\/\/doi.org\/10.1182\/blood-2013-03-484642","journal-title":"Blood"},{"key":"232_CR8","doi-asserted-by":"publisher","first-page":"614704","DOI":"10.3389\/fimmu.2021.614704","volume":"12","author":"C Keenan","year":"2021","unstructured":"Keenan C, Nichols KE, Albeituni S, 2021. Use of the JAK inhibitor ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis. Front Immunol, 12:614704. https:\/\/doi.org\/10.3389\/fimmu.2021.614704","journal-title":"Front Immunol"},{"issue":"3","key":"232_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.idnow.2020.10.010","volume":"51","author":"GQ Meng","year":"2021","unstructured":"Meng GQ, Wang JS, Wang YN, et al., 2021. Successful treatment of cytomegalovirus-induced hemophagocytic lymphohistiocytosis with ruxolitinib as a first-line treatment. Infect Dis Now, 51(3):311\u2013313. https:\/\/doi.org\/10.1016\/j.idnow.2020.10.010","journal-title":"Infect Dis Now"},{"issue":"6","key":"232_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/bjh.13373","volume":"169","author":"S Parampalli Yajnanarayana","year":"2015","unstructured":"Parampalli Yajnanarayana S, St\u00fcbig T, Cornez I, et al., 2015. JAK1\/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms. Br J Haematol, 169(6):824\u2013833. https:\/\/doi.org\/10.1111\/bjh.13373","journal-title":"Br J Haematol"},{"key":"232_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1743-422X-5-47","volume":"5","author":"PI Rafailidis","year":"2008","unstructured":"Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al., 2008. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J, 5:47. https:\/\/doi.org\/10.1186\/1743-422X-5-47","journal-title":"Virol J"},{"issue":"20","key":"232_CR12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1182\/blood.2020005364","volume":"135","author":"AM Risitano","year":"2020","unstructured":"Risitano AM, Peffault de Latour R, 2020. Ruxolitinib for steroid-resistant acute GVHD. Blood, 135(20):1721\u20131722. https:\/\/doi.org\/10.1182\/blood.2020005364","journal-title":"Blood"},{"key":"232_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coi.2017.08.004","volume":"49","author":"FE Sepulveda","year":"2017","unstructured":"Sepulveda FE, de Saint Basile G, 2017. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol, 49:20\u201326. https:\/\/doi.org\/10.1016\/j.coi.2017.08.004","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"232_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00277-013-1936-5","volume":"93","author":"CH Shen","year":"2014","unstructured":"Shen CH, Hwang CE, Chen YY, et al., 2014. Hepatitis B virus reactivation associated with ruxolitinib. Ann Hematol, 93(6):1075\u20131076. https:\/\/doi.org\/10.1007\/s00277-013-1936-5","journal-title":"Ann Hematol"},{"issue":"10","key":"232_CR15","doi-asserted-by":"publisher","first-page":"ofy262","DOI":"10.1093\/ofid\/ofy262","volume":"5","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Chung TWH, Chan JFW, et al., 2018. Emergence of cytomegalovirus mononucleosis syndrome among young adults in Hong Kong linked to falling seroprevalence: results of a 14-year seroepidemiological study. Open Forum Infect Dis, 5(10):ofy262. https:\/\/doi.org\/10.1093\/ofid\/ofy262","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"232_CR16","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.jaad.2013.09.035","volume":"70","author":"LX Tong","year":"2014","unstructured":"Tong LX, Jackson J, Kerstetter J, et al., 2014. Reactivation of herpes simplex virus infection in a patient undergoing ruxolitinib treatment. J Am Acad Dermatol, 70(3):e59\u2013e60. https:\/\/doi.org\/10.1016\/j.jaad.2013.09.035","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"232_CR17","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJMc1502524","volume":"372","author":"AM Vannucchi","year":"2015","unstructured":"Vannucchi AM, 2015. Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med, 372(17):1670\u20131671. https:\/\/doi.org\/10.1056\/NEJMc1502524","journal-title":"N Engl J Med"},{"issue":"6","key":"232_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1631\/jzus.B2000842","volume":"22","author":"X Wang","year":"2021","unstructured":"Wang X, Dai CY, Yin YF, et al., 2021. Blocking the JAK2\/STAT3 and ERK pathways suppresses the proliferation of gastrointestinal cancers by inducing apoptosis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(6):492\u2013503. https:\/\/doi.org\/10.1631\/jzus.B2000842","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2300232\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:02:46Z","timestamp":1702573366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2300232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2300232","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Fangfang GENG, Meifang YANG, Xuan ZHANG, Hong ZHAO, De ZHOU, and Jianhua HU declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"All procedures followed were in accordance with the ethical standards of the Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (No. IIT20221226A) and with the Helsinki Declaration of 1975, as revised in 2013. Informed consent was obtained from the subject for being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}